Last reviewed · How we verify
NCT05420532
Designing Virtual Reality-based Software for People With Multiple Sclerosis
NA trial testing Exergaming in Multiple Sclerosis in 15 participants. Status unknown.
15 July 2023
Quick facts
| Lead sponsor | Yuzuncu Yil University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 30 January 2022 |
| Primary completion | 15 July 2023 |
| Estimated completion | 30 August 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Exergaming
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Yuzuncu Yil University
Who can join
Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to designing virtual reality-based testing and rehabilitation software for people with multiple sclerosis and assess the feasibility of software. Also, the effects of an 8-week virtual reality-based upper extremity training in persons with multiple sclerosis will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05420532
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exergaming
Trials testing the same drug.
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
- NCT07304167 — Investigation of the Effectiveness of a Exergame Program in Women With Fibromyalgia · NA · recruiting
- NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
- NCT06886867 — Comparing Exergaming and Usual Care Physical Therapy in Nursing Home Residents · NA · recruiting
- NCT05908357 — Study of Two Exercises Protocols for Autism Spectrum Disorder · NA · completed
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Yuzuncu Yil University trials
Trials by the same sponsor.
- NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
- NCT07523399 — Joint Health, Balance and Quality of Life in Adults With Hemophilia A · recruiting
- NCT07416877 — The Effects of Dual-Task Exercises on Parameters After Total Knee Arthroplasty · NA · not yet recruiting
- NCT07243925 — Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patient · NA · active not recruiting
- NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05420532 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuzuncu Yil University
- Last refreshed: 15 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420532.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing